This technology is a method for increasing the healthy lifespan in aging populations.
Certain pharmaceutical compounds and xenomolecules have been suggested to improve quality of life and extend longevity in the elderly. However, these treatments have not been fully validated for their efficacy and safety in clinical populations.
This technology enhances bodily function during aging and extends the lifespan. Taurine levels naturally decline during aging, and this deficiency is associated with increased morbidity and reduced organ function. Through dietary supplementation of taurine, this technology reduces senescence and extends the lifespan to promote healthy aging in older populations.
This technology has been validated in preclinical murine and primate models of aging.
Vijay K. Yadav, Ph.D.
Patent Pending
IR CU22148
Licensing Contact: Jerry Kokoshka